Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 8:00 PM JST
Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A41D13/11 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2021/188787METHOD FOR TREATMENT OF CORONAVIRUS INFECTION
WO 23.09.2021
Int.Class A41D 13/05
AHUMAN NECESSITIES
41WEARING APPAREL
DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
13Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
05protecting only a particular body part
Appl.No PCT/US2021/022954 Applicant RENIBUS THERAPEUTICS, INC. Inventor KEYSER, Donald Jeffrey
The present invention involves a novel method for treatment of coronavirus infection, including SARS-COV-2. The method comprises administering stannous protoporphyrin and/or cyanocobalamin to a human patient at risk for developing complications from coronavirus infection. The method is particularly useful where a patient has been diagnosed with coronavirus infection or has been exposed to coronavirus but has not developed symptoms of coronavirus infection.
2.2020102080Smart COVID Mask: AI-based mask with attachment to auto-detect and kill the COVID-19 virus
AU 17.09.2020
Int.Class A41D 13/11
AHUMAN NECESSITIES
41WEARING APPAREL
DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
13Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
05protecting only a particular body part
11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
Appl.No 2020102080 Applicant Balusamy, Balamurugan PROF Inventor
The eruption of Coronavirus disease 2019 (COVID-19), caused by critical acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has killed a vast population and infected many in India and around the world, resulting in the greatest tragedy for humans. So there's an urgent need for preventive equipment like sanitizers, masks to prevent individuals from getting infected, as prevention is the only remedy for now. Apart from this, the technology can also help to fight against COVID-19 as nowadays advanced technologies are being used as a critical component in these types of scenarios. So here the proposed solution is a smart COVID Mask: Al-based mask to auto-detect and kill the coronavirus, that can detect the COVID-19 virus over any entry points of the face and sanitize it thoroughly to prevent it from entering the body. Smart COVID Mask: an Al-based mask that can auto-detect and kill the COVID-19 virus before it enters the body. The mask is equipped with sensors and disinfectant. The identified entry points of the COVID-19 virus are facial openings like nasal cavity, mouth & eyes. If we are able to kill the virus before it enters the body, then we can prevent further infection.AI-based scanner with a built-in optical Biosensor that detects the COVID-19 virus and then directs the sanitization module to kill it.
3.10932505Enzyme-enhanced anti-viral fabrics
US 02.03.2021
Int.Class A41D 13/11
AHUMAN NECESSITIES
41WEARING APPAREL
DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
13Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
05protecting only a particular body part
11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
Appl.No 17022236 Applicant Mandy Jane Ward Inventor Mandy Jane Ward

The invention provides fabrics that incorporate enzymes that inactivate microbial pathogens, particularly enveloped viral particles such as those of Influenza virus and Coronavirus such as Covid-19. The fabrics of the invention may be used in the production of various items including protective facemasks.

4.111686125Application of carrageenan to resisting of novel coronavirus
CN 22.09.2020
Int.Class A61K 31/731
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
731Carrageenans
Appl.No 202010561815.2 Applicant DALIAN POLYTECHNIC UNIVERSITY Inventor SONG SHUANG
The invention discloses application of carrageenan to resisting of novel coronavirus, and belongs to the technical field of biomedicine. The application proves that the carrageenan can obviously inhibit SARS-CoV-2 virus from infecting organism cells at the concentration of 62.5 [mu]g/mL or above. The carrageenan can be used for preparing medicines for preventing or treating coronavirus infection,and includes the forms of spray, aerosol, dry powder inhalation, lotion, ointment, liniment, nasal spray and the like. The carrageenan can also be used for preparing protective articles for preventingcoronavirus infection, wherein the protective articles include hand sanitizer, mask filter elements, air filter elements and the like.
5.20210371905SURVEILLANCE METHOD TO SCREEN ASYMPTOMATIC ESSENTIAL WORKERS FOR EXHALATION OF SARS-COV-2
US 02.12.2021
Int.Class C12Q 1/686
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6844Nucleic acid amplification reactions
686Polymerase chain reaction
Appl.No 17331151 Applicant VANDERBILT UNIVERSITY Inventor Frederick R. Haselton

Disclosed herein is a COVID-19 surveillance method for detecting exhaled virions trapped within used face masks. This is a surveillance and warning system for identifying asymptomatic and pre-symptomatic individuals, particularly essential workers required to wear masks while at work. This can include healthcare workers, first responders, nursing home personnel, postal workers, or employees at meat packing and other production facilities. A piece of filter paper can be added to the inside of a standard face mask, which can be removed at the end of a shift. Mask inserts from a group of employees can be pooled and tested using standard RT-PCR for virions collected during normal exhalation over the time the mask is worn. As envisioned, if the group test is positive, additional follow-up or contact tracing could be initiated to identify the individual or individuals requiring treatment or quarantine.

6.10757988Personal protective equipment with functionalized nanotube compositions to control pathogens such as SARS CoV-2 (coronavirus)
US 01.09.2020
Int.Class A41D 13/11
AHUMAN NECESSITIES
41WEARING APPAREL
DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
13Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
05protecting only a particular body part
11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
Appl.No 16871994 Applicant MOLECULAR REBAR DESIGN, LLC Inventor Kurt W. Swogger

Nanotube compositions may be employed in many different forms alone, and/or with surfactants, with antiviral metals, with antigens, and/or with various drugs to control pathogens like viruses e.g., SARS COVID-2, bacteria, mold, fungi, chemical or biological agents etc in masks or other personal protection equipment. The personal protection equipment such as masks reduce, control, absorb, deactivate, detoxify, and/or kill the pathogens such that a pathogen or pathogens deleterious effects are reduced and/or eliminated to a user of the mask.

7.WO/2021/209395COVID FACE MASK
WO 21.10.2021
Int.Class B01D 39/08
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
39Filtering material for liquid or gaseous fluids
08Filter cloth, i.e. woven, knitted or interlaced material
Appl.No PCT/EP2021/059456 Applicant AGA NANOTECH LTD Inventor FELLOWS, Adrian, Neville
The invention relates to a multi-layered substrate, comprising a first layer, a second layer and a third layer, wherein an acetyl donor and a peroxygen donor are entrapped between the first layer and the second layer capable of generating peracetic acid and hydrogen peroxide as biocides in the presence of moisture, and a basic salt is contained in the third layer or between the second layer and the third layer. The multi-layered substrate is suitable for face masks and provides antiviral protection, in particular a protection against SARS-CoV-2 and COVID-19.
8.WO/2021/234549ANTI-VIRAL LACTOFERRIN FACEMASK
WO 25.11.2021
Int.Class D06M 15/15
DTEXTILES; PAPER
06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D0664
15Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials with macromolecular compounds; Such treatment combined with mechanical treatment
01with natural macromolecular compounds or derivatives thereof
15Proteins or derivatives thereof
Appl.No PCT/IB2021/054233 Applicant VIRUSTATIC LTD. Inventor HOPE, Paul
A breathable biological face covering comprising a fabric material and an anti-pathogen substance on the fabric material. The anti-pathogen substance comprises a lactoferrin protein. The amount of lactoferrin protein on the fabric material may be in the range of 0.6–1.5 grams/m2 of fabric material. Another embodiment is a lactoferrin composition comprising an aqueous fluid at pH <7.0 and lactoferrin protein mixed in the aqueous fluid at a concentration of 0.6–1.5 grams per liter. This lactoferrin composition may be administered into the respiratory tract. This composition could be useful against respiratory microbial pathogen, such as influenza virus or coronavirus.
9.20210368890Antiviral Face Mask
US 02.12.2021
Int.Class A41D 13/11
AHUMAN NECESSITIES
41WEARING APPAREL
DOUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
13Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
05protecting only a particular body part
11Protective face masks, e.g. for surgical use, or for use in foul atmospheres
Appl.No 16890674 Applicant Argentum Medical, LLC Inventor Raul BRIZUELA

Disclosed herein are washable, reusable, antimicrobial and antiviral face masks and methods of their use for the reduction of transmission of infectious pathogens. Exemplary face masks are made of silver-coated material wherein activation of the silver from moisture in a user's breath kills pathogens. The disclosed face masks are useful in reducing, inhibiting or killing pathogens, such as SARS-CoV-2, that contact the face mask within 2 hours of continuous contact.

10.20210290793Ultraviolet Face Shield Systems for Reducing Germ Transmission
US 23.09.2021
Int.Class A61L 2/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
2Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
02using physical phenomena
08Radiation
10Ultra-violet radiation
Appl.No 16826274 Applicant Matthew Jay Tung Inventor Matthew Jay Tung

Several embodiments relating to ultraviolet face shield systems and methods of use are provided herein. Such face shield systems feature an ultraviolet light source capable of inactivating, destroying, or killing germs, bacteria, viruses, or other pathogens such as human coronavirus COVID-19, and protecting individual(s) from infection.